Contacts · НУХТ ↗ УКР EN
Department of
Biotechnology
and Microbiology
Apply 2026

«Science at the Core of All Processes», or How to Become a Member of the FARMAK JSC Team

«Science at the Core of All Processes», or How to Become a Member of the FARMAK JSC Team

This was precisely the topic of the webinar organized by representatives of Farmak JSC – Iryna Voskres (a recruitment and onboarding specialist of the HR recruitment department) and Valentyn Motsar (a process engineer of the technological development department) for third- and fourth-year students of speciality G21 «Biotechnology and Bioengineering».

As always, our students share their impressions of the meeting.

Marta Shulha, student BT-4-2: «Since 2010 the company has been a leader of Ukraine’s pharmaceutical market; it is a modern European-level enterprise and the largest exporter of medicines, so listening to the company’s speakers is a genuine pleasure.

The main speaker was Valentyn Motsar, a medicines development engineer, a graduate of the Department of Biotechnology and Microbiology with four years of production experience. The speaker explained all aspects of medicine manufacturing and the main nuances of drug development in an engaging and informative way. What I found especially interesting and new was the creation of a generic drug and how it differs from the reference product. Numerous other informative points—such as the analysis of the range of medicines on Ukraine’s pharmaceutical market, the study of the API substance for pharmaco-technological indicators and the conclusions drawn from them, the excipients examined during the development of the tablet composition and technology, and the study of their kinetics in vitro and in vivo—were clearly explained to the future specialists.

For us students, it is a delight to attend events of this kind.

I sincerely thank Farmak JSC for the opportunity to study and learn new things.»

Daria Syniavska, student BT-3-4: «First of all, I would like to note that the meeting with a graduate of our department and now a leading employee of Farmak JSC—Valentyn Motsar—was very substantive, informative, and useful in the context of the realities of the modern world.

Farmak JSC makes treatment with modern, effective medicines accessible, as the company is engaged in the development and creation of generic medicines that serve as alternatives to innovative drugs. Generic medicines contain the same qualitative and quantitative composition of active substances and the same dosage form as reference drugs, but they cost significantly less because they do not undergo multi-stage, expensive toxicological and clinical trials.

I also found Valentyn’s account particularly interesting: that, at one of the oldest pharmaceutical companies in Ukraine—Farmak JSC—there is an opportunity to engage in research work, since the company has a modern research complex, including multidisciplinary laboratories equipped with high-tech equipment, as well as an innovative R&D centre—a facility where scientific and technical research is carried out to develop new samples of medicines.

Thus, for a pharmaceutical company of this level, the priority is, above all, the manufacture of high-quality products and support for the young generation in scientific work.

There is certainly a great deal more that could be said about this meeting, as it left me with a host of pleasant impressions, but the main thing is that this meeting was very useful and motivating for further study and for the proper application of one’s knowledge in the future.

So I would like to thank the speaker, Valentyn, for taking the time to inform the future specialists who will work in this field, as well as the Dean of the Faculty of Biotechnology and Environmental Control, Nataliia Mykolaivna Hrehirchak, who engages leading specialists from high-level companies for live communication with students, which allows us to understand exactly what a leading biotechnologist does and how one can realize oneself in the future after completing studies at one’s alma mater.

Of course, I would like to visit this enterprise and see the production layout with my own eyes, and indeed the pharmaceutical company itself from the inside, so I hope this will become possible in due course.»

Daria Blahodyr, student BT-3-2: «I would like to share my impressions of the lecture given by Farmak JSC. Thank you very much for the interesting, accessible, and substantive information. It is wonderful to draw on the experience of qualified employees, and especially of graduates of our department, and to enrich one’s store of knowledge. I would like to express special gratitude to Valentyn, as I greatly enjoyed the thorough and clear presentation of the information on each stage of manufacturing generics. It would be good to have more video lectures of this kind, as they are an excellent opportunity to hear how the theoretical knowledge one has acquired is applied in practice in large-scale production.»

Olena Dotsenko, student BT-3-2: «Everyone knows that up-to-date knowledge and useful advice can be obtained from someone who has personally travelled the whole path «from student to engineer of a technological laboratory»—that is, from someone who has studied a given question in practice, under real conditions. Valentyn Motsar, a process engineer at Farmak JSC, shared his experience, explained in an accessible way how an original medicine differs from a generic one, and described in detail the stages of creating the latter. At this meeting we became acquainted with the analysis of the range of medicines on Ukraine’s pharmaceutical market. Time flew by unnoticed, as the meeting was very informative.»

Anna Vorobei, student BT-3-1: «Even though the students are already on the threshold of the exam session, and outside the window the weather increasingly reminds us of the approaching winter holidays, gaining new knowledge is never superfluous. This time we were helped in this by a specialist of the Farmak company in the field of pharmaceutical drug development—Valentyn Motsar—a graduate of our department. His lecture, concerning the stages of creating a generic medicine, was very interesting and informative. Everything we heard allowed us to immerse ourselves in the world of pharmaceutics, to picture ourselves in the role of a technologist, and to understand from the examples provided how an enterprise operates from the laboratory to the production shop. After all, during the quarantine period there is no opportunity to visit the plant and see production in the form of an excursion. During the lecture, both fourth- and third-year students were able to follow the material presented, since over the previous years they had managed to master the basic knowledge of the relevant disciplines.»

Anastasiia Okhmakevych, student BT-3-1: «At the webinar hosted by Farmak, the speakers Iryna Voskres and Valentyn Motsar introduced us to the company’s history, its innovations, and the stages of creating a generic medicine, and also conveyed the key idea—science lies at the core of all processes! Farmak actively promotes the development of scientific research, allocating the lion’s share of its profit to this each year, and in 2023 it plans to open a cutting-edge laboratory in Kyiv where students, too, will be able to carry out scientific work.

We came to realize that what we study at the university (wet granulation, compression of tablet masses, packaging, and so on) can indeed prove useful in life after graduation.

Many thanks to Iryna Volodymyrivna and Valentyn for an informative, interesting, and useful webinar!»

Viktoriia Nehretova, student BT-3-4: «At the meeting with representatives of Farmak JSC, we were told about the company’s history and the specifics of manufacturing medicines.

Valentyn Motsar characterized the process of developing new medicines, describing each stage in detail.

It was very interesting to listen to the speakers and to learn the details of production.

Many thanks to Farmak JSC and to our department for such an opportunity!»

Kyryl Murenko, student BT-3-2: «The other day we held a video conference with representatives of the Farmak company. The information was presented in a clear and understandable form. We were briefly told about the company’s history, the stages of medicine production, and the study of substances for pharmaco-technological indicators. I would like to single out Valentyn in particular, who truly knows what he is talking about; the professionalism of the staff was immediately apparent.»

Viktoriia Bilenko, student BT-3-4: «Farmak JSC is a successful international pharmaceutical company; it is a leader in Ukraine with a continually rising standing. The values of Farmak JSC include such key aspects as growth (both within the company in Ukraine and across the whole world); professionalism, which is embodied in the work of every employee; and innovativeness. I learned that Farmak invests 15 million dollars in scientific research and development annually, has around 200 brands in its product portfolio and 100 medicines under development, and provides employment for around 250 workers. The company is innovative, as 7 hectares dedicated to the concentration of technological innovation constitute its arsenal within the pharmaceutical industry, and this includes global research on the original molecule, the manufacture of complex multi-component medicines, the production of insulins, and 100 products of theirs under development. I was intrigued by the account and the more detailed briefing on the stages of creating a generic medicine. I remembered that generic drugs are the same as reference drugs in terms of the quantitative composition of active substances and dosage form, but their advantage is that they cost less, since they do not undergo multi-stage preclinical and clinical trials.

Another advantage of the company is that it has a unique biotechnological laboratory where one can carry out scientific work and, in general, work with an eye to the future. One of the most important topics was that we were told how to become part of the friendly Farmak company. First of all, one needs to review the vacancies of interest and fill out a questionnaire, and then submit a CV. One must pass the CV screening, an interview with a specialist, and receive the results of it.

So, to sum up my impressions, I can frankly say that I enjoyed the meeting; I learned a great deal that was new and realized that I had not been mistaken in my choice of profession. I thank the organizers for giving us the opportunity to learn and to gain new knowledge and skills from companies of this scale.»

Tetiana Boiaryn, student BT-3-4: «I am sincerely grateful for the opportunity to attend this meeting and to hear information from specialists in the pharmaceutical field. I thank the organizers immensely for holding the meeting and for the time they devoted to it. Such meetings help students to grow, to learn about new discoveries, and to gain a better understanding of their speciality. I came away with positive impressions of the meeting and became acquainted with the incredibly interesting research of the other participants, which virtually made it possible to open up new horizons for myself.»

Mariia Bondarchuk and Yulianna Zabrodska, fourth-year students: ««At the webinar we were told about the company itself, and they also shared their experience and impressions of the work. The meeting was quite relaxed and open to questions; the students listened with pleasure and answered questions. We talked about medicines, their active substance, as well as “expensive” drugs and “cheap” analogues. Thank you for such an interesting and informative meeting!»